Funciones cognitivas y terapia electroconvulsiva en pacientes psiquiátricos con enfermedad afectiva
Barra lateral del artículo
Descargas
Esta obra está bajo una licencia Creative Commons Reconocimiento 3.0 Unported.
Contenido principal del artículo
Resumen
Objetivo: la terapia electroconvulsiva (TEC) se ha considerado un tratamiento seguro y eficaz para episodios de depresión mayor, para episodios maníacos y otros trastornos psiquiátricos serios. El estudio describe los efectos cognitivos de la TEC en pacientes referidos para tratamiento a una clínica privada.
Metodología: estudio descriptivo del tipo de serie de casos. En cada participante se realizó una evaluación basal antes del inicio de la TEC y otras dos (una a la semana y otra a los seis meses) después de terminado el ciclo de tratamientos, para describir el efecto de la TEC frontotemporal bilateral en la función neurocognitiva mediante el cambio, desde el estado basal hasta la evaluación final en los dominios de memoria, velocidad psicomotora, tiempo de reacción, atención compleja y flexibilidad cognoscitiva, así como en la función cognoscitiva global; y determinar su seguridad por el reporte de eventos adversos. La evaluación cognitiva se realizó con una batería de pruebas neuropsicológicas y la severidad de la enfermedad psiquiátrica se evaluó con la escala Clinical Global Impression Severity (CGI-S). Se incluyeron seis pacientes remitidos para tratamiento durante el periodo de seis meses.
Resultados: no se observaron diferencias estadísticamente significativas entre las medianas de las evaluaciones de CGI-S, ni de la función cognitiva global, así como de ninguno de los dominios evaluados.
Conclusiones: la TEC no produjo cambios en las funciones cognitivas analizadas en los seis pacientes estudiados.
Citas
Faedda GI, Becker I, Baroni A, Tondo L, Aspland E, Koukopoulos A. The origins of electroconvulsive therapy: Prof. Bini’s first report on ECT. J Affect Disord 2010; 120:12–15.
American Psychiatric Association. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging: A task force report. 2nd ed. Washington, DC: American Psychiatric Association; 2001.
Scott AIF, editor. The ECT handbook. 2nd ed. London: Royal College of Psychiatrists; 2005.
Ottosson JO, Fink M. Ethics in electroconvulsive therapy. New York: Routledge; 2004.
Abrams R. Electroconvulsive therapy. 4th ed. New York: Oxford University Press; 2002.
Burrows GD, Norman TR. Treatment-resistant unipolar depression. In: Lader M, Naber D, editors. Difficult clinical problems in psychiatry. London: Martin Dunitz; 2001:57-75.
Sachs GS. Treatment of acute depression in bipolar disorder. In: Ketter TA, editor. Advances in treatment of bipolar disorder. Arlington: American Psychiatric Publishing; 2005:57-109.
Devanand DP, Lisanby SH, Sackeim HA. Special somatic treatments. In: Dewan MJ, Pies RW, editors. The Difficult to treat psychiatric patient. Washington, DC: American Psychiatric Publishing; 2001:359-392.
Meeter M, Murre JMJ, Janssen SMJ, Birkenhager T, van den Broek WW. Retrograde amnesia after electroconvulsive therapy: A temporary effect? J Affect Disord 2011;132(1-2):216-222.
Gardner BK, O´Connor DW. A review of the cognitive effects of electroconvulsive therapy in older adults. J ECT 2008;24(1):68-80.
Mukherjee S, Sackeim HA, Schunur DR. Electroconvulsive therapy in acute manic episodes: A review of 50 years’ experience. Am J Psychiatry 1994;151:169-176.
Versiani M, Cheniaux E, Landeira-Fernandez J. Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder. A systematic review. J ECT 2011;27(2):153-164.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000.
Guy W. ECDEU Assessment manual for psychopharmacology-revised. Rockville MD: D.H.E.W. Publ. No ADM 91-338; 1976:218-222.
Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol 2006; 21(7):623-643.
CNS Vital Signs [Web site].Chapel Hill, N C: Users manual. c2003-10. Available at: www.CNSVS. com. Accessed April 18, 2011.
Gualtieri CT, Morgan DW. The frequency of cognitive impairment in patients with anxiety, depression and bipolar disorder: an unaccounted source of variance in clinical trials. J Clin Psychiatry 2008;69(7):1122-1130.
Wysokiński A, Dzienniak M, Kłoszewska I. Assessment of cognitive performance using CNS Vital Signs after electroconvulsive treatment of schizophrenia. J ECT 2014;30(1):e5-6.
Malloy FW, Small IF, Miller MJ Milstein V, Stout JR. Changes in neuropsychological test performance after electroconvulsive therapy. Biol Psychiatry 1982;17(1):61-67.
Ng C, Schweitzer I, Alexopoulos P, Celi E, Wong L, Tuckwell V, et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J ECT 2000;16(4):370-379.
Devanand DP, Verma AK, Tirumalasetti F, Sackeim HA. Absence of cognitive impairment after more than 100 lifetime ECT treatments. Am J Psychiatry 1991; 148(7):929-932.
Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Cognitive side-effects. J Affect Disord 2010;122:60-67.
Shenal BV, Harrison DW, Demaree HA. The neuropsychology of depression: A literature review and preliminary model. Neuropsychol Rev 2003;13:33-42.
Osuji IJ, Cullum CM. Cognition in bipolar disorder. Psychiatr Clin N Am 2005; 28:427-441.
Gualtieri CT, Johnson LG, Benedict KB. Neurocognition in depression: Patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci 2006;18:217- 225.
Paykel ES. Remission and residual symptomatology in major depression. Psychopathology 1998;31:5-314.
Scott J, Stanton B, Garland A, Ferrier IN. Cognitive vulnerability in patients with bipolar disorder. Psychol Med 2000;30:467-472.
Wilder-Willis KE, Sax KW, Rosemberg HL, Fleck DE, Shear PK, Strakowsky SM. Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord 2001;3:58-62.
Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacol 2007;32:244-254.
Ingram A, Schweitzer I, Ng CH, Saling MM, Savage G. A comparison of propofol and thiopentone use in electroconvulsive therapy: Cognitive and efficacy effects. J ECT 2007;23(3):158-162.
Geretsegger C, Nickel M, Judendorfer B, Rochowanski E, Novak E, Aichhorn W. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: A randomized double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy and cognitive performance. J ECT 2007;23(4):239-243.
Sackeim HA, Dillingham EM, Prudic J, Cooper T, McCall WV, Rosenquist P, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes. Arch Gen Psychiatry 2009;66(7):729-737.
Honig A, Arts BM, Ponds RWHM, Riedel WJ. Lithium induced cognitive side-effects in bipolar disorder: A qualitative analysis and implications for daily practice. Int Clin Psychopharmacol 1999;14:167-171.
Gualtieri CT, Johnson LG. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. Med Gen Med. 2006;8(3):46. Available at: http:// www.medscape.com/ viewarticle/541762. Accessed December 03, 2010.
Eschweiler GW, Vonthein R, Bode R, Huell M, Conca A, Peters O, et al. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): A short-term randomised controlled trial in pharmaco-resistant major depression. J Affect Disord 2007;101:149-157.
Harrison BE, Therrien B. Effect of antipsychotic medication use on memory in patients with Alzheimer’s disease: assessing the potential risk for accelerated recent autobiographical memory loss. J Gerontol Nurs 2007;33:11-20.
Tsao J, Shah R, Leurgans S. Impaired cognition in normal individuals using medications with anticholinergic activity occurs following several years. (Abstract S51.001). Academy of Neurology, 60th Annual Meeting, April 17, 2008.
Mankad MV, Weiner RD. Adverse effects. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing; 2010:139-148.
Prudic J, Peyser S, Sackeim HA. Subjective memory complaints: A review of patients selfassessment of memory after electroconvulsive therapy. J ECT 2000; 16:121-132.
Squire LR, Chace PM. Memory functions six to nine months after electroconvulsive therapy. Arch Gen Psychiatry 1975;32:1557-1564.